This content was produced with the help of AI and reviewed by STN editors before being published.
When most people think of Parkinson's disease, they think of tremor, slowness of movement, and postural instability. These motor symptoms are the defining features of the diagnosis, but for many people with Parkinson's, the non-motor symptoms, particularly the neuropsychiatric ones, are just as disabling and often far less well-managed.
Depression affects up to 40–50% of people with Parkinson's disease. Anxiety affects a similar proportion. Cognitive changes, ranging from mild cognitive impairment to Parkinson's dementia, are present in a majority of patients over the course of the disease. These are not peripheral concerns. They are core aspects of the Parkinson's experience that deserve specialized attention.
Parkinson's disease involves the progressive loss of dopamine-producing neurons in the substantia nigra, but the neurodegeneration doesn't stop there. The same alpha-synuclein pathology that drives motor symptoms also affects:
This means that depression in Parkinson's is not simply a psychological response to having a chronic illness. It is often a direct neurobiological consequence of the disease process itself. It requires treatment, not just acknowledgment.
Parkinson's depression has some features that distinguish it from typical major depression:
Treatment involves careful attention to dopaminergic medication optimization, often combined with antidepressants. SSRIs are generally well-tolerated in Parkinson's, though there are individual considerations. SNRIs may offer additional benefit for co-occurring anxiety and pain.
Anxiety is the most common non-motor symptom of Parkinson's disease in some series and is frequently undertreated. It takes multiple forms:
Anxiety in Parkinson's responds to similar interventions as anxiety in the general population: psychotherapy (particularly CBT adapted for Parkinson's), and pharmacotherapy when indicated.
Mild cognitive impairment (MCI) occurs in up to 40% of people newly diagnosed with Parkinson's, and Parkinson's dementia develops in a majority of patients with longer disease duration. The cognitive profile is distinct from Alzheimer's: more frontal-subcortical, with executive function, attention, and processing speed affected early, and memory relatively preserved initially.
Managing cognitive symptoms involves:
People with Parkinson's disease often face mobility challenges that make travel to in-person psychiatric appointments difficult. Telepsychiatry is particularly well-suited to this population, providing expert psychiatric care without requiring patients to navigate transportation challenges.
At Segal Telepsychiatry Network, we have experience evaluating and treating the neuropsychiatric aspects of Parkinson's disease (depression, anxiety, cognitive changes, and psychosis) via telehealth across California, Florida, and New York. We work collaboratively with your neurologist to ensure coordinated, comprehensive care.
Schedule a consultation to discuss how we can support the full spectrum of your Parkinson's care.
Segal Telepsychiatry Network serves patients in California, Florida, and New York. No referral needed. We typically schedule within days.
Get Started Today
